Hoersholm, Denmark

Jens Harald Kongsoe

This inventor holds 1 USPTO granted patent. Top assignee: Novo Nordisk A/s. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jens Harald Kongsoe. Retrieved from https://idiyas.com/inventor/jens-harald-kongsoe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jens Harald Kongsoe: Innovator in Insulin Administration

Introduction

Jens Harald Kongsoe is a notable inventor based in Hoersholm, Denmark. He has made significant contributions to the field of medical treatment, particularly in the administration of insulin for individuals with diabetes. His innovative approach aims to improve the management of insulin delivery, enhancing the quality of life for patients.

Latest Patents

Kongsoe holds a patent for an administration regime that is particularly useful in treating diseases or conditions where insulin administration is beneficial. This patent outlines a novel method involving a long-acting or ultra-long-acting insulin. The steps include optionally providing a blood sample, taking a single fasting blood glucose measurement, determining the insulin dose based on that measurement, and administering the insulin accordingly. This streamlined process is designed to optimize insulin delivery and improve patient outcomes.

Career Highlights

Kongsoe is associated with Novo Nordisk A/S, a leading global healthcare company specializing in diabetes care. His work at Novo Nordisk has allowed him to collaborate with other experts in the field, contributing to advancements in diabetes treatment and management.

Collaborations

Some of his notable coworkers include Thue Johansen and Ann Marie Ocampo Francisco. Their collective expertise has fostered an environment of innovation and collaboration, further enhancing the development of effective treatment solutions.

Conclusion

Jens Harald Kongsoe's contributions to insulin administration represent a significant advancement in diabetes care. His innovative patent and collaboration with esteemed colleagues underscore his commitment to improving patient health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…